Ark Solutions Inc
203690
Company Profile
Business description
Ark Solutions Inc operates in the Life and health sector. It conducts business through OEM manufacturing of wet tissues. The wet tissue manufacturing sector manufactures baby wet tissues, general wet tissues, bidet wet tissues, and others. The group researches and develops pharmaceuticals, cosmetics, and health-functional foods based on various biomaterials, and possesses ExoPlant Technology. Its business areas include Bio Business and Stem Cell cosmetics business.
Contact
218 Bongeunsa-ro
Gangnam-gu, 8th Floor
Seoul
KORT: +82 25452818
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
62
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
Qantas’ budget brand performing well, with segment earnings up 55%.
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,010.10 | 117.10 | -1.28% |
| CAC 40 | 7,723.76 | 69.51 | 0.91% |
| DAX 40 | 23,627.49 | 140.16 | 0.60% |
| Dow JONES (US) | 45,210.14 | 85.67 | -0.19% |
| FTSE 100 | 9,159.54 | 42.85 | 0.47% |
| HKSE | 25,343.43 | 153.12 | -0.60% |
| NASDAQ | 21,545.74 | 266.11 | 1.25% |
| Nikkei 225 | 41,938.89 | 371.60 | -0.88% |
| NZX 50 Index | 13,074.81 | 58.35 | -0.44% |
| S&P 500 | 6,451.38 | 35.84 | 0.56% |
| S&P/ASX 200 | 8,738.80 | 120.20 | -1.36% |
| SSE Composite Index | 3,813.56 | 44.58 | -1.16% |